SLC52A3 helps the gut absorb riboflavin, also called vitamin B2, so your cells can make and use energy. This gene helps your body move this vitamin from the intestine into the bloodstream. If the SLC52A3 gene does not work properly, riboflavin levels can drop and some people develop nerve-related symptoms such as hearing loss, trouble swallowing, muscle weakness, or breathing problems. Certain variants in this gene cause riboflavin transporter deficiency, a rare inherited condition.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or to regulate processes in the body. Some genes hold the instructions for producing proteins, the parts of cells that do the work. Others mainly help direct when specific processes occur, where they occur, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
SLC52A3Gene function
What if the gene works
The SLC52A3 gene helps your gut absorb riboflavin, also called vitamin B2, from food. This vitamin supports energy production and helps nerves and other tissues work properly.
Risk
What if the gene does not work
Changes in the SLC52A3 gene can reduce riboflavin transport and cause riboflavin transporter deficiency, often with hearing loss, muscle weakness, and breathing or swallowing problems. Milder or more severe variants can influence when symptoms start and how marked they are.
Treatment
What does that mean for your treatment
People with pathogenic variants in the SLC52A3 gene are usually treated with high dose riboflavin (vitamin B2), a well-established gene-linked therapy. Starting riboflavin early can improve or stabilize nerve, breathing, hearing, and feeding symptoms, and treatment is often continued long term. Care may still be adjusted to a person’s symptoms, but riboflavin is the main treatment choice tied to this gene.
Conditions associated with SLC52A3
Gene function
What if the gene works
Your body uses the SLC52A3 gene to take in riboflavin, also called vitamin B2, from food. This vitamin is needed for cells to make energy and carry out many routine chemical jobs. Most of this gene's work happens in the lining of the small intestine, where it helps bring riboflavin into the body.
The SLC52A3 gene makes a transporter that brings riboflavin from digested food into cells lining the small intestine. This is a key step in how the SLC52A3 gene helps absorb riboflavin for the rest of the body.
In tissues where it is active, this gene helps move riboflavin across the cell surface and into the cell. That gives cells access to the vitamin they need for normal daily work.
Riboflavin taken up through this transporter can be converted into forms that many enzymes use to release energy from food. By helping supply vitamin B2, the SLC52A3 gene supports steady routine cell activity.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help create normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC52A3 gene can weaken the cell-surface transporter that moves riboflavin (vitamin B2) into cells, often by changing its shape, stability, or placement in the cell membrane. In practice, how SLC52A3 gene variants affect riboflavin transport depends on the change: some leave partial activity, while more disruptive variants greatly reduce or stop transport. This spectrum can influence how early riboflavin transporter deficiency appears and how pronounced its features become.
How variants are linked to conditions
Pathogenic variants in the SLC52A3 gene cause riboflavin transporter deficiency, so SLC52A3 gene variants are linked to a rare inherited neurologic condition often called Brown-Vialetto-Van Laere syndrome type 2. People with this diagnosis may develop hearing loss, weakness affecting speech or swallowing, breathing problems, and nerve symptoms, with severity varying from person to person. Older medical reports may describe a similar presentation as Fazio-Londe syndrome.
A variant is not necessarily a diagnosis
Variants in genes are a usual part of human biology and are widespread in the general population. Most do not directly affect health and instead reflect natural human variation. For many genes, carrying a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC52A3, risk is mainly shaped by inheritance: the condition usually happens when a child inherits two nonworking copies, one from each parent. Symptoms can vary a lot even within the same family. There is not broadly confirmed evidence that lifestyle or environmental factors meaningfully change the chance of having this gene-related condition.
Inheritance of SLC52A3 variants
SLC52A3-related conditions are inherited in an autosomal recessive pattern. In practical terms, how SLC52A3 variants are inherited means a person usually develops the condition only when both copies of the SLC52A3 gene carry a disease-causing variant, with one changed copy inherited from each parent. Parents who each carry one variant are often unaffected carriers. For each pregnancy, two carrier parents have a 25% chance of having an affected child, a 50% chance of having a carrier child, and a 25% chance of having a child without the familial variants.
What does my SLC52A3 result mean for my family?
For families of people with an SLC52A3-related condition, close relatives may also carry the gene change, even if they feel well. Brothers and sisters can sometimes be affected or be carriers, and parents are usually carriers. Other relatives, such as aunts, uncles, and cousins, may also carry the same change, so the result can matter beyond one person.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the SLC52A3 gene, doctors use genetic testing on a blood or saliva sample. SLC52A3 genetic testing reads the gene's DNA sequence and looks for variants that may help explain symptoms or confirm a diagnosis. Results are reviewed in a lab and reported as pathogenic, uncertain, likely benign, or benign.
When should I consider getting a genetic test?
Consider testing for changes in the SLC52A3 gene if there is unexplained hearing loss, muscle weakness, trouble swallowing, or breathing problems that started in childhood or early adult life, especially if similar problems run in the family. Testing can help confirm riboflavin transporter deficiency, a condition that may improve with vitamin B2 treatment.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but what it can show depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person than for another. These differences are common and can influence both how well a medicine helps and how likely someone is to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape the way a person responds to medication. It focuses on gene drug patterns to clarify why the same treatment may work differently in different people. With many medicines, genes affect both how the body processes a drug and how strong its effects may be. This understanding can support more informed, individualized treatment decisions. More information on this topic is available in the LearnHub.
Drugs influenced by the SLC52A3 gene
When should I seek medical advice?
There isn’t yet a broadly confirmed role for this gene in guiding how medicines are chosen or adjusted, so questions about side effects, new symptoms, or treatment changes are best discussed with your doctor.
History
Throughout history, doctors described families with a rare pattern of hearing loss, weakness, and breathing problems that was later recognized as riboflavin transporter deficiency. For many years, these cases were grouped under names such as Brown-Vialetto-Van Laere syndrome and Fazio Londe syndrome, based on the symptoms people showed. In the late 2000s, researchers linked part of this picture to the SLC52A3 gene, helping unify conditions that had once been considered separate. Over time, scientists’ understanding of the gene’s function has changed, and genetic findings helped explain why some people improved with riboflavin treatment. This discovery was an important step because it connected a long described clinical syndrome with a specific inherited cause.